Tiaan Ayurvedic 2018
Tiaan Ayurvedic 2018
Tiaan Ayurvedic 2018
To,
BSE Limited,
Listing Dept, /Dept. of Corporate Service,
Phiroz leejeebhay Towers,
Dalal Street,
Mumbal -
400001.
Dear Sirs,
Pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) regulations 2015, we
aresubmitting herewith the Annual Report of the Company for the Financial Year 2017-18 approved and
adopted by the members as per the provision of the Companies Act, 2013, at the Annual General
Meeting of the Company held on Thursday, the 27m September, 2018 at 10:00 am. Amantran Hall, Near
Vadodara Airport, Harani, Shyam Nagar, Kareiibagh, Vadoda ra -
390 022‘
Managing Director
Registered office: 405, Patel Ashwamegh Complex, letalpur Road, Near Dairy Den Circle, Sayajigun}, Vadodara. Gujarai~ 390005
6 063590 93939
Corporate oflice: Crystal Plan, 610- A-Wing, Opp. Infinity Mall, Link Road, Andheri (West), Mumbai- 400053 6 98333 19639
@rachnacapitnl@gmail.com | mwuiaanonlinecom
CIN Nov: L85100G11992PLC017397
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
1
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Board of Directors:
Auditors: : Mehul M. Shah & Co, Chartered Accountants, Shop No. 8 Pranam CHS.
Ltd. Nr. State Bank of Hyderabad, Chiku Wadi, Borivali (W) Mumbai-
400 092.
Registered Office: : 405, Patel Ashwamegh Complex, Sayajigunj Vadodara, 390 005.
Contact No: 06359093939.
Corporate Office: : Crystal Plaza, 610, A-Wing, Opp. Infinity Mall, Link Road, Andheri (W)
Mumbai – 400 053. Contact No: 09833319639.
CIN: : L85100GJ1992PLC017397
Share Transfer Agents: : MCS Share Transfer Agent Ltd, 101, Shatdal Complex 1st Floor, Opp.
Bata Showroom Ashram Road, Ahemdabad- 380009.
2
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
INDEX
7. Statement of Profit & Loss for the year ended 31st March, 2018 48-49
8. Statement of Cash Flow for the year ended 31st March, 2018 50-51
3
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
NOTICE
Notice is hereby given that the 26th Annual General Meeting of the members of M/s. Tiaan Ayurvedic & Herbs
Limited (Formerly Known as Rachana Capital and Securities Limited) will be held on Thursday, the 27 th September,
2018 at 10.00 A.M., at Amantran Hall, Near Vadodara Airport, Harani, Shyam Nagar, Karelibagh, Vadodara -
390022, Gujarat to transact the Following Businesses:
Ordinary Business:
1. To receive, consider and adopt the Audited Balance Sheet as at 31 st March, 2018, Profit and Loss Account for
the year ended 31st March, 2018, the Reports of the Board of Directors on the working and activities of the
Company and the Auditor’s Report on the Balance Sheet and Accounts.
Special Business:
2. To appoint Mr. Satish Bhagat(DIN:07967667) as an Independent Director and in this regard, to consider and if
thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT Mr. Satish Bhagat(DIN:07967667), who was appointed as an Additional Director of the Company
by the Board of Directors with effect from 18th October, 2017 and who holds office up to the date of this Annual
General Meeting under Section 161(1) of the Companies Act, 2013 (‘the Act’) and Articles of Association of the
Company, but who is eligible for appointment and in respect of whom the Company has received a notice in
writing under Section 160(1) of the Act from a Member, proposing his candidature for the office of Director, be
and is hereby appointed as a Director of the Company.”
“RESOLVED FURTHER THAT pursuant to the provisions of Sections 149, 152, Schedule IV and other applicable
provisions, if any, of the Act and the Companies (Appointment and Qualifications of Directors) Rules, 2014, as
amended from time to time, appointment of Mr. Satish Bhagat (DIN: 07967667), who has submitted a declaration
that he meets the criteria for independence as provided in Section 149(6) of the Act and Regulation 16(b) of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as an Independent Director of the
Company, not liable to retire by rotation, for a term of 5 years, with effect from 18th October, 2017 up to 17th
October, 2022, be and is hereby approved.”
3. To appoint Mr. Sanjay Patel, (DIN: 08099142) as an Independent Director and in this regard, to consider and if
thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT Mr. Sanjay Patel, (DIN: 08099142), who was appointed as an Additional Director of the Company
by the Board of Directors with effect from 14th April, 2018 and who holds office up to the date of this Annual
General Meeting under Section 161(1) of the Companies Act, 2013 (‘the Act’) and Articles of Association of the
Company, but who is eligible for appointment and in respect of whom the Company has received a notice in
writing under Section 160(1) of the Act from a Member, proposing his candidature for the office of Director, be
and is hereby appointed a Director of the Company.”
“RESOLVED FURTHER THAT pursuant to the provisions of Sections 149, 152, Schedule IV and other applicable
provisions, if any, of the Act and the Companies (Appointment and Qualifications of Directors) Rules, 2014, as
amended from time to time, appointment of Mr. Sanjay Patel, (DIN: 08099142), who has submitted a declaration
that he meets the criteria for independence as provided in Section 149(6) of the Act and Regulation 16(b) of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as an Independent Director of the
Company, not liable to retire by rotation, for a term of 5 years, with effect from 14th April, 2018 up to 13th April,
2023, be and is hereby approved.”
4
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
4. To appoint Mrs. Kajal Jain, (DIN: 08129655) as an Independent Director and in this regard, to consider and if
thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT Mr. Kajal Jain, (DIN: 08129655), who was appointed as an Additional Director of the Company by
the Board of Directors with effect from 24th May, 2018 and who holds office up to the date of this Annual General
Meeting under Section 161(1) of the Companies Act, 2013 (‘the Act’) and Articles of Association of the Company,
but who is eligible for appointment and in respect of whom the Company has received a notice in writing under
Section 160(1) of the Act from a Member, proposing her candidature for the office of Director, be and is hereby
appointed a Director of the Company.”
“RESOLVED FURTHER THAT pursuant to the provisions of Sections 149, 152, Schedule IV and other applicable
provisions, if any, of the Act and the Companies (Appointment and Qualifications of Directors) Rules, 2014, as
amended from time to time, appointment of Mrs. Kajal Jain, (DIN: 08129655), who has submitted a declaration
that she meets the criteria for independence as provided in Section 149(6) of the Act and Regulation 16(b) of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as an Independent Director of the
Company, not liable to retire by rotation, for a term of 5 years, with effect from 24th May, 2018 up to 23rd May,
2023, be and is hereby approved.”
5
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
NOTES:
1. A MEMBER ENTITLED TO ATTEND AND VOTE AT THE ANNUAL GENERAL MEETING (THE “MEETING”) IS
ENTITLED TO APPOINT A PROXY TO ATTEND AND VOTE ON A POLL INSTEAD OF HIMSELF AND THE PROXY NEED
NOT BE A MEMBER OF THE COMPANY. THE INSTRUMENT APPOINTING THE PROXY SHOULD, HOWEVER, BE
DEPOSITED AT THE REGISTERED OFFICE OF THE COMPANY NOT LESS THAN FORTY-EIGHT HOURS BEFORE THE
COMMENCEMENT OF THE MEETING.
A person can act as a proxy on behalf of members, not exceeding fifty and holding in the aggregate not more than
ten percent of the total share capital of the Company, carrying voting rights. A member holding more than ten
percent of the total share capital of the Company carrying voting rights may appoint a single person as proxy and
such person shall not act as a proxy for any other person or Shareholder.
2. Corporate members intending to send their authorized representatives to attend the Meeting pursuant to
section 113 of the Companies Act, 2013 are requested to send to the Company, a certified copy of the Board
Resolution together with Specimen signatures of those representative(s) authorised under said resolution to
attend and vote on their behalf at the Meeting.
3. Brief resume of Directors including those proposed to be appointed / re-appointed, nature of their expertise in
specific functional areas, names of companies in which they hold directorships and memberships / chairmanships
of Board Committees, shareholding and relationships between directors inter-se as stipulated under Regulation
36(3) Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation 2015 with
the Stock Exchange, are provided in the annexure to the notice of the Meeting.
4. Explanatory statement under Section 102 of the Companies Act, 2013 in respect of special business is annexed
hereto.
(a) bring their copy of the Annual Report and Attendance Slip with them at the Annual General Meeting.
(b) quote their Regd. Folio Number/DP and Client ID Nos. in all their correspondence with the Company or its
Registrar and Share Transfer Agent.
6. In case of joint holders attending the Meeting, only such joint holder who is higher in the order of names will be
entitled to vote.
7. Annual Report and AGM Notice is available at the website of the Company at www.tiaanonline.com in the
Investor Relations section.
8. The Register of Members and Share Transfer Books of the Company will remain closed from Monday, the
24th September, 2018 to Thursday, the 27th September, 2018 (both days inclusive) for the purpose of Annual
General Meeting.
9. Relevant documents referred to in the accompanying Notice and the Statement is kept open for inspection by
the members at the Registered Office of the Company on all working days, except Saturdays, during business hours
up to the date of the Meeting.
10. Members desirous of obtaining any information in respect of Accounts of the Company are requested to send
their queries in writing to the company at its Registered Office so as to reach at least seven days before the date of
the meeting.
6
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
11. The Securities and Exchange Board of India (“SEBI”) has mandated the submission of Permanent Account
Number (PAN) by every participant in securities market. Members holding shares in electronic form are, therefore,
requested to submit the PAN to their Depository Participants with whom they are maintaining their demat
accounts. Members holding shares in physical form can submit their PAN details to the Company or to the
Registrar and Share Transfer Agent.
12. SEBI has also mandated that for registration of transfer of securities, the transferee(s) as well as transferor(s)
shall furnish a copy of their PAN card to the Company for registration of transfer of securities.
13. The Notice of the AGM along with the Annual Report 2017-18 is being sent by electronic mode to those
Members whose e-mail addresses are registered with the Company / Depositories, unless any Member has
requested for a physical copy of the same. For Members who have not registered their e-mail addresses, physical
copies are being sent by the permitted mode. Members may note that this Notice and the Annual Report 2017-18
will also be available on the Company’s website viz. www.tiaanonline.com.
14. The route map showing directions to reach the venue of the 26th AGM is annexed.
15. Members, desiring any information relating to the accounts, are requested to write to the Company at an
early date so as to enable the management to keep the information ready.
(A) In compliance with the provisions of Section 108 of the Companies Act, 2013 and Rule 20 of the Companies
(Management and Administration) Rules, 2014 as amended thereto and Regulation 44 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, and the Secretarial Standard on General Meeting (SS-
2) issued by The Institute of Company Secretaries of India (ICSI), the Company is pleased to provide Members with
a facility to exercise their right to vote at the Annual General Meeting (AGM) by Electronic means and the
business may be transacted through Electronic Voting (e-Voting) Services.
(B) The facility for voting through ballot/polling paper shall be made available at the venue of the AGM. The
members attending the meeting, who have not already cast their vote through remote e-voting shall be able to
exercise their voting rights at the meeting. The members who have already cast their vote through remote e-voting
may attend the meeting but shall not be entitled to cast their vote again at the AGM.
(C) The voting rights of members shall be in proportion to their shares of the paid up equity share capital of the
Company as on the cut-off date of 21st September 2018.
(D) Person who is not a member as on cut-off date should treat this notice for information purpose only.
(E) Members having any grievances connected with the remote e-voting can contact MCS SHARE TRANSFER
AGENT LIMITED, 101, Shatdal Complex, Opp. Bata Show Room, Ashram Road, Ahmedabad – 380 009.
(F) The Company has appointed Mr. Suhas Bhattbhatt of M/s. S Bhattbhatt & Co, Practicing Company Secretaries
(Membership No. 11975) as the Scrutinizer for conducting the remote e-voting and the voting process at the AGM
in a fair and transparent manner.
(G) The Scrutinizer shall after the conclusion of voting at the AGM, will first count the votes cast at the meeting and
thereafter unblock the votes cast through remote e- voting in the presence of at least two witnesses not in the
employment of the Company and shall make, not later than two days of the conclusion of the AGM, a consolidated
scrutinizer’s report of the total votes cast in favour or against, if any, to the Chairman or a person authorized by
him in writing, who shall countersign the same and declare the result of the voting forthwith.
7
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
(H) The Resolution shall be deemed to be passed on the date of the AGM, subject to receipt of sufficient votes in
favour of the resolutions through a compilation of remote e-voting results and voting held at the AGM.
The Results shall be declared by the Chairman or a person authorized by him in writing within 48 hours of
conclusion of AGM of the Company. The result declared along with the Scrutinser’s report shall be placed on the
Company’s website viz. www.tiaanonline.com on the agency’s website viz. www.cdslindia.com and communicated
to BSE Limited, where shares of the Company are listed.
(i) The voting period begins on Monday, 24th September, 2018 at 9.00 a.m. and ends on Wednesday, 26th
September, 2018 at 5.00 p.m. During this period shareholders of the Company, holding shares either in physical
form or in dematerialized form, as on the cut-off date i.e. 21st September, 2018, may cast their vote electronically.
The e-voting module shall be disabled by CDSL for voting after 5.00 p.m. on Wednesday, 26th September, 2018 at
5.00 p.m.
(ii) The shareholders should log on to the e-voting website www.evotingindia.com.
(iii) Click on Shareholders.
(iv) Now Enter your User ID;
a. For CDSL : 16 digits beneficiary ID;
b. For NSDL : 8 Character DP ID followed by 8 Digits Client ID;
c. Members holding shares in Physical Form should enter Folio Number registered with the Company.
(v) Next enter the Image Verification as displayed and Click on Login.
(vi) If you are holding shares in demat form and had logged on to www.evotingindia.com and voted on an earlier
voting of any Company, then your existing password is to be used.
(vii) If you are a first time user follow the steps given below :
• Members who have not updated their PAN with the Company/Depository Participant are
requested to use the first two letters of their name and the 8 digits of the sequence number
in the PAN field.
• In case the sequence number is less than 8 digits enter the applicable number of 0’s
before the number after the first two characters of the name in CAPITAL letters. Eg. If your
name is Ramesh Kumar with sequence number 1 then enter RA00000001 in the PAN field.
Dividend Bank Enter the Dividend Bank Details or Date of Birth (in dd/mm/yyyy format) as recorded in your
Details OR Date demat account or in the company records in order to login.
of Birth (DOB) If both the details are not recorded with the depository or company please enter the
member id / folio number in the Dividend Bank details field as mentioned in instruction (iv).
8
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
In case you have any queries or issues regarding e-voting, you may refer the frequently Asked Questions (“FAQs”)
and e-voting manual available at www.evotingindia.com under help section or write an email to
helpdesk.evoting@cdslindia.com.
17. You can also update your mobile number and e-mail id in the user profile details of the folio which may be used
for sending future communication(s).
18. Any person, who acquires shares of the Company and become member of the Company after dispatch of the
Notice of AGM and holding shares as of the cut-off date i.e. 21st September, 2018 may obtain the login ID and
password by sending a request at helpdesk.evoting@cdslindia.com or rachnacapital@gmail.com. However, if you
are already registered with CDSL for remote e-voting then you can use your existing user ID and password for
casting your vote. If you forgot your password, you can reset your password by using “Forgot User
Details/Password” option available on helpdesk.evoting@cdslindia.com.
19. A person, whose name is recorded in the register of members or in the register of beneficial owners maintained
by the depositories as on the cut-off date only shall be entitled to avail the facility of remote e-voting as well as
voting at the AGM through ballot paper.
20. The Chairman shall, at the AGM, at the end of discussion on the resolutions on which voting is to be held, allow
voting with the assistance of scrutinizer, by use of ballot paper for all those members who are present at the AGM
but have not cast their votes by availing the remote e-voting.
21. All documents referred to in the accompanying notice and Statutory Registers are open for inspection at the
registered office of the Company on all working days (barring Saturday and Sunday) between 11.00 a.m. to 1.00
9
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
22. The entire Annual Report is also available on the Company’s website www.tiaanonline.com.
23. With the aim of curbing fraud and manipulation risk in physical transfer of securities, SEBI has notified the
SEBI (Listing Obligations and Disclosure Requirements) (Fourth Amendment) Regulations, 2018 on June 8, 2018
to permit transfer of listed securities only in the dematerialized form with a depository. In view of the above
and the inherent benefits of holding shares in electronic form, we urge the shareholders holding shares in
physical form to opt for dematerialization.
24. The Requirement to place the matter relating to auditor appointment for ratification by the members at
every Annual General Meeting is done away with vide notification dated May, 7 2018 issued by the Ministry of
Corporate Affairs, New Delhi. Accordingly, no resolution is proposed for ratification of appointment of auditors,
who were appointing in the Annual General Meeting held on September, 28 2017.
10
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
11
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
EXPLANATORY STATEMENT PURSUANT TO SECTION 102(1) OF THE COMPANIES ACT, 2013 (“the Act”):
Item No.2:
The Board commends the Ordinary Resolution set out at Item No. 2 of the Notice for approval by the Members.
None of the Directors or Key Managerial Personnel of the Company or their relatives is, in any way, concerned or
interested in the Resolution set out at Item No. 2 of the Notice.
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have
proposed that Mr. Satish Bhagat (DIN: 07967667), has been appointed as an Independent Director of the
Company. The appointment of Mr. Satish Bhagat shall be effective upon approval by the members in the Meeting.
Mr. Satish Bhagat is not disqualified from being appointed as a Director in terms of Section 164 of the Act and has
given his consent to act as a Director.
The Company has received a declaration from Mr. Satish Bhagat that he meets the criteria of independence as
prescribed both under sub-section (6) of Section 149 of the Act and under Regulation 25 of Securities and
Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015. In the opinion of the
Board, Mr. Satish Bhagat, fulfills the conditions for his appointment as an Independent Director as specified in the
Act and under Regulation 25 (2) of Securities and Exchange Board of India (Listing Obligation and Disclosure
Requirement) Regulation 2015, Mr. Satish Bhagat is an independent of the management and possesses
appropriate skills, experience and knowledge.
Mr. Satish Bhagat born on 14th January, 1976 is holding a Graduate Degree in commerce from Nagpur University,
India. Before coming on Tiaan Ayurvedic & Herbs Limited’s Board of Director, he has hold senior positions with
Many leading financial Services firms for more than two decades. His experience and Expertise includes Accounts,
stock broking management and operation; financial Services like equity, commodity, insurance, mutual fund,
portfolio management; branch and Franchisee network development etc. He does not hold any shares of the
Company in his name. Keeping in view his vast expertise and knowledge, it will be in the interest of the Company
that Mr. Satish Bhagat be appointed as an Independent Director of the Company. Copy of the draft letter for
appointment of Mr. Satish Bhagat as an Independent Director setting out the terms and conditions is available for
inspection by members at the registered office of the Company. This Statement may also be regarded as a
disclosure under Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement)
Regulation, 2015.
Save and except Mr. Satish Bhagat and his relatives, to the extent of their shareholding interest, if any, in the
Company, none of the other Directors / Key Managerial Personnel of the Company / their relatives are in any way,
concerned or interested, financially or otherwise, in the resolution set out at Item No. 2 of the Notice.
Item No.3:
The Board commends the Ordinary Resolution set out at Item No. 3 of the Notice for approval by the Members.
None of the Directors or Key Managerial Personnel of the Company or their relatives is, in any way, concerned or
interested in the Resolution set out at Item No. 3 of the Notice.
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have
proposed that Mr. Sanjay Patel, (DIN: 08099142), has been appointed as an Independent Director of the Company.
12
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
The appointment of Mr. Sanjay Patel, shall be effective upon approval by the members in the Meeting.
Mr. Sanjay Patel, is not disqualified from being appointed as a Director in terms of Section 164 of the Act and has
given his consent to act as a Director.
The Company has received a declaration from Mr. Sanjay Patel, that he meets the criteria of independence as
prescribed both under sub-section (6) of Section 149 of the Act and under Regulation 25 of Securities and
Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015. In the opinion of the
Board, Mr. Sanjay Patel, fulfills the conditions for his appointment as an Independent Director as specified in the
Act and under Regulation 25 (2) of Securities and Exchange Board of India (Listing Obligation and Disclosure
Requirement) Regulation 2015, Mr. Sanjay Patel, is independent of the management and possesses appropriate
skills, experience and knowledge.
Mr. Sanjay Patel, is Commerce Graduate having more than five years of experience in the field of ayurveda
Marketing Product. He does not hold any shares of the Company in his name. Keeping in view his expertise and
knowledge, it will be in the interest of the Company that Mr. Sanjay Patel be appointed as an Independent Director
of the Company. Copy of the draft letter for appointment of Mr. Sanjay Patel as an Independent Director setting
out the terms and conditions is available for inspection by members at the registered office of the Company. This
Statement may also be regarded as a disclosure under Securities and Exchange Board of India (Listing Obligation
and Disclosure Requirement) Regulation, 2015.
Save and except Mr. Sanjay Patel and his relatives, to the extent of their shareholding interest, if any, in the
Company, none of the other Directors / Key Managerial Personnel of the Company / their relatives are in any way,
concerned or interested, financially or otherwise, in the resolution set out at Item No. 3 of the Notice.
Item No.4:
The Board commends the Ordinary Resolution set out at Item No. 4 of the Notice for approval by the Members.
None of the Directors or Key Managerial Personnel of the Company or their relatives is, in any way, concerned or
interested in the Resolution set out at Item No. 4 of the Notice.
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors have
proposed that Mrs. Kajal Jain(DIN:08129655), has been appointed as an Independent Director of the Company.
The appointment of Mrs. Kajal Jain shall be effective upon approval by the members in the Meeting.
Mrs. Kajal Jain, is not disqualified from being appointed as a Director in terms of Section 164 of the Act and has
given her consent to act as a Director.
The Company has received a declaration from Mrs. Kajal Jain, that she meets the criteria of independence as
prescribed both under sub-section (6) of Section 149 of the Act and under Regulation 25 of Securities and
Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015. In the opinion of the
Board, Mrs. Kajal Jain fulfills the conditions for her appointment as an Independent Director as specified in the Act
and under Regulation 25 (2) of Securities and Exchange Board of India (Listing Obligation and Disclosure
Requirement) Regulation 2015, Mrs. Kajal Jain is an independent of the management and possesses appropriate
skills, experience and knowledge.
13
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Mrs. Kajal Jain is Commerce Graduate having a very rich experience in the field of Ayurveda & Herbal Medicine.
She does not hold any shares of the Company in her name. Keeping in view her expertise and knowledge, it will be
in the interest of the Company that Mrs. Kajal Jain be appointed as an Independent Director of the Company. Copy
of the draft letter for appointment of Mrs. Kajal Jain as an Independent Director setting out the terms and
conditions is available for inspection by members at the registered office of the Company. This Statement may also
be regarded as a disclosure under Securities and Exchange Board of India (Listing Obligation and Disclosure
Requirement) Regulation, 2015.
Save and except Mrs. Kajal Jain and her relatives, to the extent of their shareholding interest, if any, in the
Company, none of the other Directors / Key Managerial Personnel of the Company / their relatives are in any way,
concerned or interested, financially or otherwise, in the resolution set out at Item No. 4 of the Notice.
14
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
BOARD’S REPORT
To,
The Members,
Tiaan Ayurvedic & Herbs Limited
Your Directors are pleased to present their 26th Annual Report and the audited Financial Statement for the year
ended 31st March, 2018.
2. Performance Review:
The revenue for the current financial year increased to 1021.72 lakh compare to previous year 53.21 lakh mainly
due to expanding market size and better marketing efforts. The net profit after tax increase to 30.27 lakh compare
to 2.86 lakh. The company intends to position itself as a leading player in the Ayurvedic products market -
personal care and wellness as well as health and hygiene. There exists significant potential in the
distribution market and the company expects good traction here. We propose to sell products across all
age groups to urban, semi urban and rural customers enhancing our reach across the country. Our belief
is that setting up a strong distribution network will be a key driving force for the company. We propose
to mobilize a channel partner network that will enhance our distribution. The company lays emphasis on
personal care products such as Ayurvedic soaps, creams, scrubs, facial care products and shampoos to
help consumers live a healthier life. Our health and nutrition products will enable a chemical free
lifestyle for consumers. We believe that Ayurveda is a need of the hour given the extent of likely damage
that chemical based products cause to human health.
15
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
3. Dividend
With a view to conserve resources, your Directors have thought it prudent not to recommend any
dividend for the financial year under review.
A sum of Rs. 3,026,532 has been transferred to the General Reserves of the company. This reflects well on the
financial strength of the Company.
With change of Object during previous financial year it was eminent to change the place of Registered Office which
may be suitable for working condition looking at the nature of business. The company’s registered office was
shifted to main business hub of Vadodara (405, Patel Ashwa Megh Complex, Jetalpur Road, Sayajigunj, Vadodara).
During the year under review company has started its Corporate office at: 703, Purva Plaza, Shimpoli Road,
Boriwali (W), Mumbai 400 053. The corporate office is now further moved to Unit No.610, 6‘" Floor, A—wing, in
Crystal Plaza Premises, Co-Operative Society Ltd; Opp Infinity Mall, New Link Road, Andheri (West), Mumbai.
Company’s Accounts are generally maintained at the corporate office situated at MUMBAI.
No significant material orders have been passed by the Regulators or Courts or Tribunals which would impact the
going concern status of the Company and its future operations.
8. Subsidiary Companies
During the year under review, the Company does not have any subsidiary company.
The Company has in placed adequate and effective Internal Financial Controls with reference to financial
statements. During the year, such controls were tested and upgraded and no reportable material weaknesses in
the design or operation were observed.
During the year under review, your Company has not directly or indirectly -
a) given any loan to any person or other body corporate other than usual advances envisaged in a
contract of supply of materials, if any;
b) given any guarantee or provided security in connection with a loan to any other body corporate
or person; and
c) acquired by way of subscription, purchase or otherwise, the securities of any other body
corporate.
16
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
No related party transaction(s) entered into during the financial year. The Company has not entered into any
contract, arrangement or transaction with any related party which could be considered as material as defined
under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board has approved a policy for related party transactions which has been uploaded on the website of the
Company (www.tiaanonline.com).
As there are no related party transaction(s) during the year, the no approval of Audit Committee as well as the
Board required to be obtained.
Related party transactions under Accounting Standard – AS 18 are disclosed in the notes to the financial
statements. Prescribed Form No. AOC-2 pursuant to clause (h) of sub-section (3) of Section 134 of the Act and Rule
8(2) of the Companies (Accounts) Rules, 2014 is furnished as Annexure – A to this report.
Pursuant to section 134(5) of the Companies Act, 2013, the board of directors, to the best of their knowledge and
ability, confirm that:
a) in the preparation of annual accounts for the year ended March 31, 2018, the applicable accounting
standards read with requirements set out under Schedule III to the Act, have been followed and there are
no material departures from the same;
b) they have selected such accounting policies and applied them consistently and made judgments and
estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the
Company at March 31, 2018 and of the Profit of the Company for the year ended on that date;
c) they have taken proper and sufficient care for the maintenance of adequate accounting records in
accordance with the provisions of the this Act for safeguarding the assets of the Company and for
preventing and detecting fraud and other irregularities;
e) they have laid down internal financial controls to be followed by the Company and that such internal
financial controls are adequate and are operating effectively; and
f) they have devised proper systems to ensure compliance with the provisions of all applicable laws and that
such systems are adequate and operating effectively.
17
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Mr. Nitin Mistry appointed as Company Secretary & Compliance Officer of the Company with effect from
01st June, 2017.
None of the Company’s directors are disqualified from being appointed as a director as specified in Section 164 of
the Act.
Brief profiles of the Directors proposed to be appointed/re-appointed are annexed to the Notice convening Annual
General Meeting.
The Company has received necessary declarations from all Independent Directors of the Company confirming that
they meet the criteria of independence laid down in Section 149(6) of the Companies Act, 2013 as well as under
Regulation 25 and 16(1)(b) of SEBI (LODR) Regulations. There has been no change in the circumstances which may
affect their status as independent director during the year.
The Board of Directors has carried out an annual evaluation of its own performance, Board committees and
Individual Directors pursuant to the provisions of the Act and the Corporate Governance requirements as
prescribed by Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements),
Regulations 2015 (“SEBI Listing Regulations”).
The performance of the Board was evaluated by the Board after seeking inputs from all the Directors on the basis
of the criteria such as the Board composition and structure, effectiveness of Board processes, information and
functioning, etc.
The performance of the Committees was evaluated by the Board after seeking inputs from the Committee
members on the basis of the criteria such as the composition of Committees, attendance, prior study of materials
given, participation at the meetings, level and effectiveness of Committee meetings, etc.
The Board and the Nomination and Remuneration Committee (“NRC”) reviewed the performance of the Individual
Directors on the basis of the criteria such as the contribution of the individual Director to the Board and
Committee meetings like preparedness on the issues to be discussed, meaningful and constructive contribution
and inputs in meetings, etc. In addition, the Chairman was also evaluated on the key aspects of his role.
18
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
In compliance with the requirements of SEBI Regulations, 2015, the Company has put in place a familiarization
programme for the Independent Directors to familiarize them with their role, rights and responsibilities as
Directors, the working of the Company, nature of the industry in which the Company operates, business model etc.
The Nomination and Remuneration Committee has laid down the criteria for Directors appointment and
remuneration including criteria for determining qualification, positive attributes and independence of a Director.
The following attributes/criteria for selection have been laid by the Board on the recommendation of the
Committee:
• the candidate should possess the positive attributes such as leadership, entrepreneurship, business
advisor or such other attributes which in the opinion of the Committee are in the interest of the
Company;
• the candidate should be free from any disqualification as provided under Sections 164 and 167 of the
Companies Act, 2013;
• the candidate should meet the conditions of being independent as stipulated under the Companies Act,
2013 and Listing Agreement entered into with Stock Exchanges, in case of appointment as an independent
director; and
• the candidate should possess appropriate educational qualification, skills, experience and knowledge in
one or more fields of finance, law, management, sales, marketing, administration, corporate governance,
technical operations, infrastructure or such other areas or disciplines which are relevant for the
Company’s business.
During the year under review, Five (5) Meetings of the Board of Directors, were held on 13th May, 2017, 10th
August, 2017, 28th September, 2017, 14th November, 2017, 12th February, 2018.
As provided under Section 92(3) of the Act, the extract of annual return is given in Annexure–B in the prescribed
Form MGT-9, which forms part of this report.
The Audit Committee of the Board of Directors meets the criteria laid down under Section 177 of the Companies
Act, 2013, read with Regulation 18 of Securities and Exchange Board of India (Listing Obligation and Disclosure
Requirement) Regulation, 2015 in the terms of reference to the Audit Committee.
21. Material Changes and Commitments, if any, affecting the Financial position of the Company which have
occurred between the end of Financial Year of the Company to which the Financial Statement relate and the
date of the Report
There were no material changes and commitments that have affected the financial position of the Company which
have occurred between the financial year ended on 31st March, 2018 and the report dated 14th August, 2018.
19
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
In terms of the provisions of Regulation 34 of the SEBI (Listing Obligations and Disclosures Requirements)
Regulation 2015, the Management Discussion and Analysis has been given hereunder
What most important drawback is lack of qualified traditional Ayurveda practitioners. The WHO
recommends a doctor to patient ratio of 1:1000, but when we look at data provided by the
Ministry of AYUSH, we find that the country has 0.3 Ayurveda doctors for every 1000 patients!
This basically means that demand far exceeds supply. Although there has been growing
consumer demand for Ayurvedic products, thanks to increased awareness about preventive and
natural care, and the efforts of the Ministry of AYUSH, there are still a number of barriers to
Ayurveda’s adoption and growth. Commercial importance of the herbal industry has been greatly
recognized by the Indian business community, which striving towards becoming a global leader in
this sector. The uniqueness of Ayurveda, as an alternative system of medicine and that of many
herbal products of Indian origin; have a cutting edge to win over a specific share of the world
market.
There’s now a dramatic shift in the market, with more consumers moving online and many
finding easier access to Ayurvedic and other natural products. Over the past year, at all
Ayurveda, we have already witnessed a 30% month on month increase in traffic, hitting all time
20
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
high page views on month to month passes. It therefore comes as no surprise that the projected
Ayurvedic products market growth for the next few years at a CAGR of 16%. Considering that
Ayurveda e-commerce is still in its nascent stages, this market space is only likely to expand
further in the coming years.
Some of the threats include Indian habits where the report shows lesser population still not fully
convinced with ayurvedic products as alternate medicines. The active components of the herbal
drugs prescribed were not known, and even today many drugs still need further exploration for
their active constituent characterization and elucidation of the mechanism of action. Several
issues like, the variation in the potency due to difference in species, absence of an integrated
coding for every species used commonly in TSMs, varying geographical location of growth, and
incorrect identification and adulteration of drugs, non-uniform quality control standards,
differences in processing methods.
Indian market for ayurvedic products is anticipated to grow at a quick rate over the coming years.
Organic skincare products are achieving fast grip in India and the market is anticipated to expand
even further. In addition to expanding consumer base, anti-ageing and anti-wrinkle creams are
anticipated to fuel the market growth. The focus of the management is to create brand name for
their products considering keen competitions prevailing in the ayurvedic market. There exists
significant potential in the distribution market and the company expects good traction
here. We propose to sell products across all age groups to urban and rural area
enhancing our reach across the country. Our belief is that setting up a strong
distribution network will be a key driving force for the company. We propose to mobilize
a channel partner network that will enhance our distribution. The company lays
emphasis on personal care products such as Ayurvedic soaps, creams, scrubs, facial care
products and shampoos to help consumers live a healthier life. Our health and nutrition
products will enable a chemical free lifestyle for consumers.
The management is conscious about the changing scenario in industry and review take place
regularly.
21
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
less favorable terms or key suppliers may cease or reduce their operations.
However, the Company plans well in advance to procure the raw materials and purchases its
Raw Materials from the domestic reputed supplier located in different parts of the country to
mitigate risk relating to availability of raw materials.
The Company’s internal control systems are supplemented by periodic reviews by the
Management. The Audit Committee reviews its findings and recommendations at periodic
intervals. Company’s internal control system is adequate considering the nature, size and
complexity of its business.
g. Cautionary Statement:
Statements in the Management Discussion and Analysis describing the Company’s objectives,
projections, estimates, expectations may be ‘forward looking statements’ within the meaning of
applicable securities laws and regulations. Actual results could differ materially from those
expressed or implied. Important factors that could make a difference to the Company’s
operations include financial position of the company, economic conditions affecting demand /
supply, price conditions in the domestic and overseas market in which the company operates,
changes in the government regulations, tax laws and other statutes.
The Company has in place a Risk Management Policy pursuant to Section 134 of the Companies Act and Regulation
21 of SEBI (LODR) Regulations. It establishes various levels of accountability and overview within the Company,
while vesting identified managers with responsibility for each significant risk.
The Internal Audit Department facilitates the execution of Risk Management Practices in the Company, in the
22
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
areas of risk identification, assessment, monitoring, mitigation and reporting. Through this program, each Function
carried on works, addresses opportunities and risks through a comprehensive approach aligned to the Company’s
objectives. The Company has laid down procedures to inform the Audit Committee as well as the Board of
Directors about risk assessment and management procedures and status.
This risk management process, which is facilitated by internal audit, covers risk identification, assessment, analysis
and mitigation. Incorporating sustainability in the process also helps to align potential exposures with the risk
appetite and highlights risks associated with chosen strategies. The major risks forming part Risk Management
process are linked to the audit.
The Audit Committee of the Board of the Company has been entrusted with the task to frame, implement and
monitor the risk management plan for the Company and it is responsible for reviewing the risk management plan
and ensuring its effectiveness with an additional oversight in the area of financial risks and controls. Major risks
identified by the businesses and functions are systematically addressed through mitigating actions on a continuing
basis.
The Company has already constituted a Corporate Social Responsibility (CSR) Committee in accordance with
Section 135 of the Companies Act, 2013.
For the Company, Social Responsibility is a key element of accountability and it will continue to strive in its
behavior and actions to surpass the levels of minimum statutory compliance. The Company believes in the
sustainable growth and prosperity of its stakeholders and views its responsibilities not only as business
responsibilities but as Ethical and Social as well.
The CSR policy of the Company is placed on the website of the Company (www.tiaanonline.com)
However, in view of inadequate profit, the company has not pursued any initiative on CSR activities.
The Company’s commitment to excellence in Health and Safety is embedded in the Company’s core values. The
Company has a stringent policy which drives all employees to continuously break new ground in safety
management for the benefit of people, property, environment and the communities where we operate on sites.
The Company respects human rights, values its employees and their communities. The Company considers safety,
environment and health as the management responsibility. Regular employee training programmes are in place
throughout the Company on Safety, Environment and Health and has well identified and widely covered safety
management system in place for ensuring, not only the safety of employees but surrounding population of the
works as well.
The Company has zero tolerance for sexual harassment at the workplace and has adopted a Policy on Prevention,
Prohibition and Redressal of Sexual Harassment at the Workplace, in line with the provisions of the Sexual
Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Rules there under.
The Policy aims to provide protection to employees at the workplace and prevent and redress complaints of sexual
harassment and for matters connected or incidental thereto, with the objective of providing a safe working
environment, where employees feel secure. All employees of the Company, those of contractors as well as
23
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
trainees are covered under this Policy. The policy of the Company is placed on the website of the Company
(www.tiaanonline.com)
No complaint was received from any employee during the financial year 2017-2018 and hence no complaint is
outstanding as on 31.03.2018 for redressal.
There is a Whistle Blower Policy in the Company and that no personnel have been denied access to the Chairman
of the Audit Committee. The policy provides for adequate safeguards against victimization of persons who use vigil
mechanism. The Whistle Blower Policy is posted on the Company’s website www.tiaanonline.com
The Board has laid down a code of conduct for board members and senior management personnel of the
Company. The code incorporates the duties of independent directors as laid down in the Companies Act, 2013. The
said code of conduct is posted on Company’s website www.tiaanonline.com. The Board members and senior
management personnel have affirmed compliance with the said code of conduct.
The Board has adopted a revised Code of Prevention of Insider Trading based on the SEBI (Prohibition of Insider
Trading) Regulations, 2015. The same has been placed on the website of the Company www.tiaanonline.com. All
the Directors, senior management employees and other employees who have access to the unpublished price
sensitive information of the Company are governed by this code. During the year under Report, there has been
due compliance with the said code of conduct for prevention of insider trading.
No significant material orders have been passed by the Regulators or Courts or Tribunals which would impact the
going concern status of the company and its future operations.
As per SEBI LODR, Compliance with the provisions of regulation 17 through 27 and clauses (b) to of sub –
regulations 46 and Para C, D and E of schedule V is not mandatory for the time being, in respect of the following
class of Companies:
a) Companies having paid –up equity share capital not exceeding Rs.10 crore and Net Worth
not exceeding Rs.25 Crore, as on the last day of previous financial year;
b) The listed entity which has listed its specified securities on the SME Exchange;
As such our Company falls in the ambit of aforesaid exemption Consequently Corporate Governance does not
forms part of the Annual Report for the Financial Year 2017-18. However, the Company is following industry best
corporate governance standards.
The human resource plays a vital role in the growth and success of an organization. The Company has maintained
cordial and harmonious relations with employees across various locations.
Your Company continuously invests in attraction, retention and development of talent on an ongoing basis. A
24
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
number of programs that provide focused people attention are currently underway. Your Company thrust is on the
promotion of talent internally through job rotation and job enlargement.
The Company has not accepted any deposits from public and as such, no amount on account of principal or
interest on deposits from public, was outstanding as on the date of the balance sheet.
34. Conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo
Pursuant to the Rule 5(2) & (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules,
no employee of the Company was paid remuneration exceeding the prescribed limits, during the financial year
2017-2018.
36. Insurance
All the properties and insurable interests of the Company including buildings, Plants & Machineries and Stocks,
have been adequately insured.
The paid-up equity share capital of the Company as at 31st March, 2018 is Rs. 3,10,38,000. The Company currently
has no outstanding shares issued with differential rights, sweat equity or ESOS.
38. Auditors
Statutory Auditors:
M/s. Mehul M. Shah, Chartered Accountants, were appointed as the statutory auditors of the Company for a
period of five years at the Annual General Meeting (AGM) of the Company held on 28th September, 2017 to
hold office from the conclusion of 25th AGM till the conclusion of 30th AGM to be held in 2022. As per the
provisions of Section 139(1) of the Act, their appointment for the above tenure is subject to ratification by
members at every AGM.
Vide notification dated May 7, 2018 issued by Ministry of Corporate Affairs, the requirement of seeking
ratification of appointment of statutory auditors by members at each AGM has been done away with.
Accordingly, no such item has been considered in notice of the 26th AGM.
The Auditors’ Report read with the notes to the accounts referred to therein are self-explanatory and
therefore, do not call for any further comments. There are no qualifications, reservations or adverse remarks
made by the Auditors.
Secretarial Auditors:
Pursuant to the provisions of Section 204 of the Act and the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014, the Board of Directors of the Company had appointed Mr. Suhas
25
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Bhattbhatt of M/s. S Bhattbhatt & Co, Practicing Company Secretaries to undertake the Secretarial Audit of
the Company for the year ended March 31, 2018. The Secretarial Audit Report is annexed as Annexure C.
Cost Auditors:
Your Company does not require to get its cost records audited by the qualified Cost Auditors, in view of non
applicability, No appointment of Cost Auditors has been made.
39. Acknowledgement
The Board places on record its deep appreciation for the continued support received from various clients, vendors
and suppliers and Bankers, Government Authorities, Employees at all levels and Stakeholders, in furthering the
interest of the Company.
26
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
(Pursuant to clause (h) of sub-section (3) of section 134 of the Act and Rule 8(2) of the Companies (Accounts) Rules,
2014)
Form for disclosure of particulars of contracts/arrangements entered into by the Company with related parties
referred to in sub-section (1) of section 188 of the Companies Act, 2013 including certain arms length transactions
under third proviso thereto.
Name(s) of the Nature of Duration of Salient terms of the Date(s) of Amount Date on which the
related party contracts/ the contracts or approval paid as special resolution
and nature of arrangem Contracts / Arrangements or by the advance, was passed in General
relationship ents/ arrangements/ Transactions including Board if any Meeting as required
transacti- transactions value, under first proviso to
ions if any Section 188.
Not Applicable
Name(s) of the Nature of Duration of Salient terms of Date(s) of Amount Date on which the
related party contracts/ Contracts / the contracts or approval by the paid as special resolution
and nature of arrangements arrangemen arrangements Board advances was passed in
relationship / ts / or transactions , if any General Meeting
transactions transaction including the as required under
s value, if any, per First proviso to
annum Section 188.
Ranjitmal Rathod Salary 3 Years Rs.600,000/- Not Applicable None Not Applicable
27
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
CIN L85100GJ1992PLC017397
Registration date 27/03/1992
Name of the Company Tiaan Ayurvedic & Herbs Limited
Category / Sub-Category of the Company Company having Share Capital
Address of the registered office and contact 405, Patel Ashwamegh Complex, Sayajigunj Vadodara, 390
details 005
Whether listed company (Yes/No) Yes
Name, address and contact details of MCS Share Transfer Agent Ltd, 101, Shatdal Complex 1st
Registrar and Transfer Agent, if any Floor, Opp. Bata Showroom Ashram Road, Ahemdabad-
380009
Sl. No. Name and Description of main products/ services NIC Code of the % to total
Product / turnover of the
service company
1. Ayurvedic & Herbs Product 99931 100
IV. Shareholding Pattern (Equity share capital breakup as percentage of Total Equity):
(i) Category-wise Shareholding :
28
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Sub total (A)(1) 808360 -- 808360 26.04 749660 -- 749660 24.16 1.88
(2) FOREIGN
a) NRI-individuals -- -- -- -- -- -- -- -- --
b) Other Individuals -- -- -- -- -- -- -- -- --
c) Bodies Corporate -- -- -- -- -- -- -- -- --
d) Banks/FI -- -- -- -- -- -- -- -- --
e) Any Other -- -- -- -- -- -- -- -- --
Sub Total (A)(2) -- -- -- -- -- -- -- -- --
Total Shareholding
of Promoter (A)= 808360 -- 808360 26.04 749660 -- 749660 24.16 1.88
(A)(1) + (A)(2)
B) Public
Shareholding
1) Institutions
a) Mutual Funds -- -- -- -- -- -- -- -- --
b) Banks / FI -- -- -- -- -- -- -- -- --
c) Central Govt. -- -- -- -- -- -- -- -- --
d) State Govt (s) -- -- -- -- -- -- -- -- --
e) Venture Cap.Fund -- -- -- -- -- -- -- -- --
f) Insurance
-- -- -- -- -- -- -- --
Companies --
g) FIIs -- -- -- -- -- -- -- -- --
h) Foreign Venture
-- -- -- -- -- -- -- --
Capital Funds --
i) Others (specify) -- -- -- -- -- -- -- -- --
Sub- total (B) (1) -- -- -- -- -- -- -- -- --
2) Non Institutions
a) Bodies Corporate 182036 110 182146 5.87 645587 20 645607 20.80 14.93
b) Individuals
i) Individual
shareholders
holding nominal 312343 190220 502563 16.19 921605 73610 995215 32.06 15.87
share capital up to
Rs. 2 lakh
ii) Individual
shareholders
holding nominal 1610731 -- 1610731 51.90 713318 -- 713318 22.98 28.92
share capital in
excess of Rs 2 lakh
c) Others (specify)
NRI & HUF
Sub Total (B)(2) 2105110 190330 2295440 73.96 2280510 73630 2354140 75.85 1.89
Total Public
Shareholding 2105110 190330 2295440 73.96 2280510 73630 2354140 75.85 1.89
(B)=(B)(1)+ (B)(2)
C. Shares held by
Custodian for GDRs -- -- -- -- -- -- -- -- --
& ADRs
29
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Grand Total
2913470 190330 3103800 100 3030170 73630 3103800 100 --
(A+B+C)
30
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
(iv) Shareholding Pattern of top ten Shareholders (Other than directors, Promoters and Holders of GDRs
and ADRs):
Sr. For each of the Top 10 Shareholders Shareholding
No.
No. of % of total
Shares shares of the
company
1. Balance Equity Broking (India) 136524 4.3986
2. Shoaib S Khan 127373 4.1038
3. Sykes & Ray Equities (I) Ltd 96635 3.1134
4. Suresh Doulatram Adnani 71600 2.3068
5. Pradeep Narendra Bhatt 63799 2.0555
6. Tradebulls Securities (P) Limited 57500 1.8526
7. Ghanshyam Virjibhai Dhaduk 55000 1.7720
8. Vibha Piyush Malde 49800 1.6045
9. Malde Piyushbhai Jentilal 38063 1.226
10. Nikhil Prabhakar Tavase 30298 0.9762
Sr. For Each of the Directors and Share Holding at the Cumulative Shareholding
No. KMP Beginning of the Year during the year
No. of Equity % of total No. of % of Total
Shares Shares of the Equity Shares of
Company Shares the
Company
1. Ranjitmal Rathod 0 0 0 0
2. Nitin Mistry 0 0 0 0
3. Vinod Sarda 0 0 0 0
(V) Indebtedness:
Indebtedness of the Company including interest outstanding / accrued but not due for payment:
(Amount in Rs)
31
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
ii) Reduction 0 0 0 0
Net Change 0 0 0 0
Indebtedness at the end of the financial
year(31.03.2018)
i) Principal Amount 0 0 0 0
ii) Interest Due but Not Paid 0 0 0 0
iii) Interest Accrued but not due 0 0 0 0
Total (i + ii + iii) 0 0 0 0
32
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
2. Stock Option 0 -- --
3. Sweat Equity 0 -- --
4. Commission 0 -- --
- As a % of profit
- Others , specify
33
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
To,
The Members,
Tiaan Ayurvedic & Herbs Limited
We have conducted the secretarial audit of the compliance of applicable statutory provisions and the adherence to
good corporate practices by Tiaan Ayurvedic & Herbs Limited (hereinafter called the Company). Secretarial Audit
was conducted in a manner that provided us a reasonable basis for evaluating the corporate conducts / statutory
compliances and expressing our opinion thereon.
Based on our verification of the Tiaan Ayurvedic & Herbs Limited’s books, papers, minute books, forms and returns
filed and other records maintained by the company and also the information provided by the company, its officers,
agents and authorised representatives during the conduct of secretarial audit and as per the explanations given to
us and the representations made by the Management, we hereby report that in our opinion, the Company has,
during the audit period covering the financial year ended on 31 st March, 2018 generally complied with the
statutory provisions listed hereunder and also that the Company has proper Board processes and compliance
mechanism in place to the extent, in the manner and subject to the reporting made hereinafter:
We have examined the books, papers, minute books, forms and returns filed and other records made available to
us and maintained by Tiaan Ayurvedic & Herbs Limited (“the Company”) for the financial year ended on 31st
March, 2018, according to the applicable provisions of:
i. The Companies Act, 2013 (‘the Act’) and the rules made there under, as applicable;
ii. The Securities Contract (Regulation) Act, 1956 (‘SCRA’) and the rules made there under;
iii. The Depositories Act, 1996 and the Regulations and Bye-laws framed there under;
iv. Foreign Exchange Management Act, 1999 and the rules and regulations made there under to the extent of
Foreign Direct Investment, Overseas Direct Investment and External Commercial Borrowings (Not
Applicable to the Company during audit period);
v. The following Regulations and Guidelines prescribed under the Securities and Exchange Board of India
Act, 1992 (‘SEBI Act’) to the extent applicable to the Company:
a. The Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011;
b. The Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 and
Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015;
c. The Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)
Regulations, 2009 (Not Applicable to the Company during audit period);
d. The Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock
Purchase Scheme) Guidelines, 1999 and The Securities and Exchange Board of India (Share Based
Employee Benefits) Regulations, 2014; (Not applicable)
e. The Securities and Exchange Board of India (Issue and Listing of Debt Securities) Regulations,
2008 (Not Applicable to the Company during audit period);
34
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
f. The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents)
Regulations, 1993 regarding the Companies Act and dealing with client;
(Not Applicable. The Company is not registered as Registrar to Issue and Share Transfer Agent
during the financial year under review)
g. The Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009;
(Not applicable. The shares of the Company are not delisted at any stock exchange, during the
year under review) and
h. The Securities and Exchange Board of India (Buyback of Securities) Regulations, 1998;
(Not applicable. The Company not bought back any shares / securities during the year under
review)
We have also examined compliance with the applicable clauses of the following:
i. Secretarial Standards issued by The Institute of Company Secretaries of India; and
ii. The Listing Agreements entered into by the Company with BSE Limited read with the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.
During the period under review, the Company has complied with the provisions of the Act, Rules, Regulations,
Guidelines, and Standards etc.
Adequate notice is not given to all directors to schedule the Board Meetings, agenda and detailed notes on agenda
during the year. A system exists for seeking and obtaining further information and clarifications on the agenda
items before the meeting and for meaningful participation at the meeting.
Majority decision is carried through while the dissenting members’ views are captured and recorded as part of the
minutes.
35
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
We further report that there are adequate system and processes in the company commensurate with size and
operation of the Company to monitor and ensure the Compliance with applicable laws, rules, regulation and
guidelines.
We further report that during the audit period there were no instances of
a. Public / Rights / Preferential Issue of Shares / Debentures / Sweat Equity
b. Redemption / Buy Back of Securities
c. Merger / Amalgamation / Re-construction etc.
d. Foreign Technical Collaboration / Equity Participation.
Suhas Bhattbhatt
Place: Vadodara Proprietor
Date: 14-08-2018 A.C.S.:11975; C.P.:10427
This Report is to be read with our letter of even date which is annexed as Annexure -1 and forms an integral part
of this report.
36
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
‘Annexure -1’
To,
The Members,
Tiaan Ayurvedic & Herbs Limited
1. Maintenance of Secretarial record is the responsibility of the management of the Company. Our
responsibility is to express an opinion on these secretarial records based on our audit.
2. We have followed the audit practices and process as were appropriate to obtain reasonable assurance
about the correctness of the contents of the Secretarial records. The verification was done on test basis to
ensure that correct facts are reflected in Secretarial records. We believe that the process and practices,
we followed provide a reasonable basis for our opinion.
3. We have not verified the correctness and appropriateness of financial records and Books of Accounts of
the Company.
4. Where ever required, we have obtained the Management representation about the Compliance of laws,
rules and regulations and happening of events etc.
5. The Compliance of the provisions of Corporate and other applicable laws, rules, regulations, standards is
the responsibility of management. Our examination was limited to the verification of procedure on test
basis.
6. The Secretarial Audit report is neither an assurance as to the future viability of the Company nor of the
efficacy or effectiveness with which the management has conducted the affairs of the Company.
Suhas Bhattbhatt
Place: Vadodara Proprietor
Date: 14-08-2018 A.C.S.:11975; C.P.:10427
37
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
CEO/CFO CERTIFICATION
The Board of Directors
Tiaan Ayurvedic & Herbs Limited
Vadodara
We hereby certify that:
(a) We have reviewed financial statements and the cash flow statement for the year ended 31st March, 2018
and that to the best of our knowledge and belief;
i. these statements do not contain any materially untrue statement or omit any material fact or
contain statements that might be misleading;
ii. these statements together present a true and fair view of the Company’s affairs and are in
compliance with existing accounting standards, applicable laws and regulations.
(b) No transaction is entered into by the company during the year which is fraudulent, illegal or violative of
the Company’s code of conduct.
(c) We accept responsibility for establishing and maintaining internal controls for financial reporting and that
we have evaluated the effectiveness of the internal control systems of the Company pertaining to
financial reporting and we have disclosed to the Auditors and the Audit Committee, deficiencies in the
design or operation of such internal controls, if any, of which we are aware and the steps we have taken
or propose to take to rectify these deficiencies.
(d) We have indicated to the Auditors and the Audit Committee:
i. significant changes in internal control over financial reporting during the year;
ii. significant changes in accounting policies during the year and that the same have been disclosed
in the notes to the financial statements; and
iii. instances of significant fraud of which we have become aware and the involvement therein, if
any, of the management or an employee having a significant role in the Company’s internal
control system over financial reporting.
For Tiaan Ayurvedic & Herbs Ltd
38
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
To
The Members of
Tiaan Ayurvedic & Herbs Ltd.
We have examined the compliance of the conditions of Corporate Governance by Tiaan Ayurvedic & Herbs Ltd
(the Company) for the year ended on 31st March, 2018, as stipulated in Regulations 17 to 27 clauses (b) to (i) of
sub-regulation (2) of Regulation 46 and para C, D & E of Schedule V of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").
The compliance of the conditions of Corporate Governance is the responsibility of the management. Our
examination was limited to the review of procedures and implementation thereof as adopted by the Company for
ensuring compliance with conditions of Corporate Governance. It is neither an audit nor an expression of opinion
on the financial statements of the Company.
In our opinion and to the best of our information and according to the explanations given to us, and the
representations made by the Directors and the Management, we certify that the Company has complied with the
conditions of Corporate Governance as stipulated in the Listing Agreement and the Listing Regulations applicable
for the respective periods as mentioned above.
We further state that such compliance is neither an assurance as to the future viability of the Company nor of the
efficiency or effectiveness with which the management has conducted the affairs of the Company.
39
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
To the Members of
TIAAN AYURVEDIC & HERBS LIMITED
Report on the Financial Statements for the F.Y. 2017-18
We have audited the accompanying financial statements of Tiaan Ayurvedic & Herbs Limited (“the Company”),
which comprise the Balance Sheet as at 31st March, 2018, the Statement of Profit and Loss, the Cash Flow
Statement for the year ended, and a summary of the significant accounting policies and other explanatory
information.
The Company’s Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act,
2013 (“the Act”) with respect to the preparation and presentation of these Financial Statements that give a true
and fair view of the financial position, financial performance and cash flows of the Company in accordance with
the accounting principles generally accepted in India, including the Accounting Standards specified under Section
133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014. This responsibility also includes
maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the
assets of the Company and for preventing and detecting frauds and other irregularities; selection and application
of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design,
implementation and maintenance of adequate internal financial controls, that were operating effectively for
ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation
of the financial statements that give a true and fair view and are free from material misstatement, whether due to
fraud or error.
Auditor’s Responsibility
Our responsibility is to express a reasonable opinion on these financial statements based on our audit.
We have taken into account the provisions of the Act, the accounting and auditing standards and matters which
are required to be included in the audit report under the provisions of the Act and the Rules made there under.
We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered
Accountants of India. Those Standards require that we comply with ethical requirements and plan and perform the
audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the
financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the
risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk
assessments, the auditor considers internal control relevant to the Company’s preparation and fair presentation of
the financial statements in order to design audit procedures that are appropriate in the circumstances. An audit
also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting
estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit
opinion on the financial statements.
40
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Opinion
In our opinion and to the best of our information and according to the explanations given to us, the financial
statements give the information required by the Act in the manner so required and give a true and fair view in
conformity with the accounting principles generally accepted in India:
a) in the case of the Balance Sheet, of the state of affairs of the Company as at March 31, 2018; and
b) in the case of the Profit and Loss Account and the statement of Cash Flow for the year ended on
March 31, 2018;
1. As required by Companies (Auditors Report) Order 2016 ('the order') issued by Central Government of
India in terms of subsection (11) of section 143 of the Act, we enclose in the “Annexure 1” a statement on
the matters specified in paragraphs 3 & 4 of the said order, to extent applicable.
2. As required by section 143(3) of the Act, we report that:
a) We have obtained all the information and explanations which to the best of our knowledge and belief
were necessary for the purpose of our audit;
b) In our opinion proper books of account as required by law have been kept by the Company so far as
appears from our examination of those books
c) The Balance Sheet, Statement of Profit and Loss and statement of Cash Flow dealt with by this Report are
in agreement with the books of account.
d) In our opinion, the aforesaid financial statements comply with the Accounting Standards specified under
Section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.
e) In our opinion there are no observations or comments on the financial, which may have an adverse effect
on the functioning of the company.
f) On the basis of the written representations received from the directors as on 31st March, 2018 taken on
record by the Board of Directors, none of the directors is disqualified as on 31st March, 2018 from being
appointed as a director in terms of Section 164 (2) of the Act.
g) With respect to the adequacy of the Internal Financial Controls over financial reporting of the Company
and the operating effectiveness of such controls, we give our separate Report in “Annexure 2"
h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the
Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of our information and
according to the explanations given to us:
I. The Company does not have any pending litigations which would impact its financial position.
II. The Company did not have any long-term contracts including derivative contracts for which there were
any material foreseeable losses.
III. There were no amounts which were required to be transferred to the Investor Education and Protection
Fund by the Company.
IV. The disclosure regarding details of specified bank notes held and transacted during 8 November, 2016 to
30 December 2016 has not been made since the requirement does not pertain to financial year ended
31st March, 2018.
Mehul Shah
Date: 24th May, 2018 Proprietor
Place: Vadodara M. No. 044044
FR No 141907W
41
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
In terms of the information and explanations sought by us and given by the company and the books and records
examined by us in the normal course of audit and to the best of our knowledge and belief, we state that: -
1) a) The Company has a regular program of physical verification of its fixed assets by which all the fixed
assets are verified in a phased manner over a period of two years. In our opinion, the periodicity of
physical verification is a reasonable having regards to the size of the Company and nature of its
assets. Pursuant to the program a portion of the fixed assets has been physically verified by the
management, during the year and no material discrepancies have been notice on such verification.
b) According to the information and explanations received by us, and on the basis of our examination
of the records of the company, the title deeds of immovable properties as disclosed in the Note E to
the financial statement of the Company.
2) Physical verification of inventory has been conducted by the management at reasonable intervals as
required under clause 3(ii).
3) The Company has not granted loans, secured or unsecured to any companies, firms, Limited Liability
Partnerships or other parties covered in the register maintained under section 189 of the Companies
Act, 2013. Hence the reporting requirement under clause (iii) of the said order does not arise.
4) Based on our scrutiny of the Company’s records and according to the information and explanations
received by us from the management, we are of the opinion that in respect of loans and guarantees
given, investments made, and securities purchased by the company, the provisions of section 185
and 186 of the Companies Act, 2013 have been complied with.
5) In our opinion and according to information and explanations given to us, the Company has not
accepted any deposits from the public and hence the reporting requirement under clause (v) of the
said order does not arise.
6) Being a trading company having turnover below prescribe limit, the provisions of section 148(1) of
the Act with regard to the maintenance of cost records are not applicable to the Company.
7) a) Based on our scrutiny of the Company’s Book of Account and other records and according to the
information and explanations received by us from the management, we are of the opinion that the
company is regular in depositing with appropriate authorities undisputed statutory dues applicable
to it and no undisputed amounts payable in respect of any statutory dues were outstanding as at
31st March, 2018 for a period of more than six months from the date they became payable.
b) According to the records of the company and the information and explanations received by us
from the management, there are no disputed statutory dues outstanding in the name of the
company.
8) Based on our audit procedures and according to the information and explanations given to us, we
are of the opinion, the company has not defaulted in repayment of dues to a financial institution,
bank, Government or dues to debenture holders.
9) According to the records of the company, the company has neither raised any moneys by way of
Initial Public Offer or Further Public Offer (including debt instrument) nor has the company raised
42
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
any term loans during the Financial Year start from 01/04/2017 to 31/03/2018. Hence, in our opinion
the reporting requirement under clause (ix) of the said order does not arise.
10) Based upon the audit procedures performed and according to the information and explanations
given to us, no fraud by the company or any fraud on the company by its officers or employees has
been noticed or reported during the course of our audit, that causes the financial statements to be
materially misstated.
11) According to the records of the company, Managerial remuneration has been paid or provided
during the year under audit is within the limit of provision of companies act, 2013.
12) In our opinion and to the best of our information and according to the explanations provided by the
management, we are of the opinion that the company is not a Nidhi Company. Hence, in our opinion
the reporting requirement under clause (xii) of the said order does not arise.
13) According to the information and explanations given to us and based on our examination of the
records of the Company, transactions with the related parties are in compliance with Sections 177
and 188 of the Act where applicable and details of such transactions have been disclosed in the
financial statements as required by the applicable accounting standards.
14) Based on our scrutiny of the Company’s Book of Account and other records and according to the
information and explanations received by us from the management, we are of the opinion that the
company has not made any preferential allotment or private placement of shares or fully or partly
convertible debentures during the year under review. Hence, the reporting requirement under
clause (xiv) of the said order does not arise.
15) Based on our scrutiny of the Company’s Book of Account and other records and according to the
information and explanations received by us from the management, we are of the opinion that the
company has not entered into any non-cash transactions with its directors or persons connected
with him. Hence, the reporting requirement under clause (xv) of the said order does not arise.
Mehul Shah
th
Date: 24 May, 2018 Proprietor
Place: Vadodara M. No. 044044
FR No 141907W
43
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
( Referred to in paragraph (2)g under ‘ Report on Other Legal and Regulatory Requirements ‘ in our Independent
Auditor’s Report of even date , to the members of the Company on the Financial statements for the year ended
31st March ,2018).
Report on the Internal Financial Controls under Clause (i) of Sub-section 3 of Section 143 of the Companies Act,
2013 (“the Act”)
We have audited the internal financial controls over financial reporting of the Company as of Tiaan Ayurvedic &
Herbs Limited 31st March, 2018 in conjunction with our audit of the financial statement of the Company for the
year ended on that date.
The Company’s management is responsible for establishing and maintaining internal financial controls. These
responsibilities include the design, implementation and maintenance of adequate internal financial controls that
were operating effectively for ensuring the orderly and efficient conduct of its business, including adherence to
company’s policies, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy
and completeness of the accounting records, and the timely preparation of reliable financial information, as
required under the Companies Act, 2013.
Auditors’ Responsibility
Our responsibility is to express an opinion on the Company’s internal financial controls over financial reporting
based on our audit. We conducted our audit in accordance with the Guidance Note on Audit of Internal Financial
Controls Over Financial Reporting (the “Guidance Note”) and the Standards on Auditing, issued by ICAI and
deemed to be prescribed under section 143(10) of the Companies Act, 2013, to the extent applicable to an audit of
internal financial controls, both applicable to an audit of Internal Financial Controls and, both issued by the
Institute of Chartered Accountants of India. Those Standards and the Guidance Note require that we comply with
ethical requirements and plan and perform the audit to obtain reasonable assurance about whether adequate
internal financial controls over financial reporting was established and maintained and if such controls operated
effectively in all material respects.
Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial
controls system over financial reporting and their operating effectiveness. Our audit of internal financial controls
over financial reporting included obtaining an understanding of internal financial controls over financial reporting,
assessing the risk that a material weakness exists, and testing and evaluating the design and operating
effectiveness of internal control based on the assessed risk. The procedures selected depend on the auditor’s
judgement, including the assessment of the risks of material misstatement of the financial statements, whether
due to fraud or error.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit
opinion on the Company’s internal financial controls system over financial reporting.
44
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
A company's internal financial control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. A company's internal financial control over
financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in
reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the
company are being made only in accordance with authorisations of management and directors of the company;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorised acquisition, use, or
disposition of the company's assets that could have a material effect on the financial statements.
Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of
collusion or improper management override of controls, material misstatements due to error or fraud may occur
and not be detected. Also, projections of any evaluation of the internal financial controls over financial reporting
to future periods are subject to the risk that the internal financial control over financial reporting may become
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.
Opinion
In our opinion, the Company has, in all material respects, an adequate internal financial controls system over
financial reporting and such internal financial controls over financial reporting were operating effectively as at
31st March 2018.
Mehul Shah
Date: 24th May, 2018 Proprietor
Place: Vadodara M. No. 044044
FR No 141907W
45
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
46
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Mehul Shah
Proprietor Vinod Sarda Rakesh Nizare
M. No. 044044 Chief Financial Officer Non Executive Director
FR No.: 141907W
Place: Vadodara Satish Bhagat
Date: 24th May, 2018 Independent Director
47
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Statement of Profit and Loss for the year ended 31 , March, 2018 st
48
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Mehul Shah
Proprietor Vinod Sarda Rakesh Nizare
M. No. 044044 Chief Financial Officer Non Executive Director
FR No.: 141907W
Place: Vadodara Satish Bhagat
Date: 24th May, 2018 Independent Director
49
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
50
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
year
Cash on hand 158457 9606
Balances with banks
On current accounts 68791 80000
On EEFC accounts
On deposit accounts
Total cash and cash equivalents 227248 89606
Mehul Shah
Proprietor Vinod Sarda Rakesh Nizare
M. No. 044044 Chief Financial Officer Non Executive Director
FR No.: 141907W
Place: Vadodara Satish Bhagat
Date: 24th May, 2018 Independent Director
51
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
A. Share Capital:
Sr Particular 31st March, 2018 31st March, 2017
No. s (Rs.) (Rs.)
a. Authorized Shares
32,00,000 Equity Shares of Re. 10 each 32,000,000 32,000,000
b. Issued, Subscribed and Fully Paid up Shares
31,03,800 Equity Shares of Re. 10 each 31,038,000 31,038,000
c. Reconciliation of shares outstanding at the beginning and at the end of the reporting period.
31st March, 2018 31st March, 2017
No. of Amount in No. of Amount in
Shares (Rs.) Shares (Rs.)
At the Beginning of the Period 3103,800 31,038,000 3103,800 31,038,000
Add: issued during the year -- -- -- --
Less: Shares bought back during the year -- -- -- --
Add: Other movements during the year -- -- -- --
Outstanding at the end of the period 3103,800 31,038,000 3103,800 31,038,000
d. -Terms/rights attached to equity shares.
-The company has only one class of equity shares having par value of Re. 10 per share. Each holder of equity
share is entitled to one vote per share.
- The Company has not declared and paid dividend on the equity shares.
-In the event of liquidation of the Company, the holders of equity shares will be entitled to receive the
realised value of the assets of the Company, remaining after payment of all preferential dues. The
distribution will be in proportion to the number of equity shares held by the shareholders.
e. 31st March, 2018 31st March, 2017
(Rs.) (Rs.)
Shares held by holding/ ultimate Nil Nil
holding company/ or their subsidiaries/
f. associates
Details of shareholders holding more than 5% shares in the Company
31st March, 2018 31st March, 2017
No. of % of No. of % of
shares holding in shares holding in
the class the class
Mega Bucks Capital Private Limited 445,000 14.34 445,000 14.34
52
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
C. Trade Payable:
Sr Particulars 31st March, 2018 31st March, 2017
No. (Rs.) (Rs.)
a. Trade Payables 13,308,324 2,106,000
Total 2,106,000
D. Short Term Provisions:
Sr. Particulars 31st March, 2018 31st March, 2017
No. (Rs.) (Rs.)
a. Provision for Taxation and Other Provisions 1,413,223 588,005
Total 1,413,223 588,005
E. Tangible Fixed Assets:
Gross Block Depreciation & Amortization Net Block
H. Trade receivables:
Sr. Particulars 31st March, 2018 31st March, 2017
No. (Rs.) (Rs.)
a. Harshika Trading Pvt Ltd 22,060,038 2,702,500
Total 22,060,038 2,702,500
53
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
M. Other Income:
Sr. Particulars 31st March, 2018 31st March, 2017
No. (Rs.) (Rs.)
a. Other Financial Income - 1415723
b. Interest 601023 8,24,354
c. Other Income 48,051 3,81,148
Total 649,074 26,21,225
O. Other Expenses:
Sr. Particulars 31st March, 2018 31st March, 2017
No (Rs.) (Rs.)
ADMINISTRATIVE EXPENSES
Sales & Marketing Expense 354,125 124,200
Listing& Processing Fees 295,000 253,000
Legal & Other Charges 86,248 365,603
Annual Issuer Charges 58,780 44,507
Repairs and Maintenance 12,456 26,400
INDIRECT EXPENSES
Accounting & Compl Charges 102,548 78,000
54
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
The Company maintains its accounts on accrual basis following the historical cost convention in
accordance with generally accepted accounting principles ["GAAP"] in India. GAAP comprises mandatory
accounting standards as prescribed under section 133 of Companies Act, 2013 (the Act) read with Rule 7
of Companies (Accounts) Rules,2014, the provisions of the Act (to the extent notified). Accounting policies
have been consistently applied except where a newly-issued accounting standard is initially adopted or a
revision to an existing accounting standard requires a change in the accounting policy hitherto in use.
B. Use of estimates
The preparation of the financial statements in conformity with Indian GAAP requires the Management to
make estimates and assumptions considered in the reported amounts of assets and liabilities (including
contingent liabilities) and the reported income and expenses during the year. The Management believes
that the estimates used in preparation of the financial statements are prudent and reasonable. Future
results could differ due to these estimates and the differences between the actual results and the
estimates are recognised in the periods in which the results are known / materialize.
C. Revenue Recognitions
• Income from sales is recognized as and when sales are complete during the accounting year.
• Revenue in respect of all other income is recognized when a reasonable certainty as to its
realization exists.
D. Employee Benefits
All Employees benefits falling due wholly within twelve month of rendering the services are classified as
short term employee benefits which include benefits like salary, wages, short term compensated,
absences and performance incentives and are recognized as expense in the period in which the employee
55
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Events which are of material nature after the balance sheet date are accounted for in the accounts.
A provision is recognized when the Company has a present obligation as a result of past events and it is
probable that an outflow of resources will be required to settle the obligation in respect of which a
reliable estimate can be made. Provisions (excluding retirement benefits) are not discounted to their
present value and are determined based on the best estimate required to settle the obligation at the
Balance Sheet date. These are reviewed at each Balance Sheet date and adjusted to reflect the current
best estimates.
The Company creates a provision when there is a present obligation as a result of past event that
probably requires and outflows of resources and a reliable estimate can be made of the amount of
obligation. A disclosure of contingent liability is made when there is possible obligation or a present
obligation that will probably not require outflow of resources or where a reliable estimate of obligation
cannot be made.
G. Taxes on income
Income tax comprises current and deferred income tax. Income tax expense is recognized directly in
equity or in other comprehensive income. Provision for Current Tax is made after taking into
consideration benefits admissible under the provisions of Income Tax Act, 1961.
Basic earnings per share is computed by dividing the profit / (loss) after tax (including the post tax effect
of extraordinary items, if any) by the weighted average number of equity shares outstanding during the
year. Diluted earnings per share is computed by dividing the profit / (loss) after tax (including the post tax
effect of extraordinary items, if any) as adjusted for dividend, interest and other charges to expense or
income relating to the dilutive potential equity shares, by the weighted average number of equity shares
considered for deriving basic earnings per share and the weighted average number of equity shares which
could have been issued on the conversion of all dilutive potential equity shares. Potential equity shares
are deemed to be dilutive only if their conversion to equity shares would decrease the net profit per share
from continuing ordinary operations.
Cash Flow Statement has been prepared in accordance with Accounting Standard 3 issued by Institute of
Chartered Accountants of India.
J. Segment Reporting
The Company operates in a single segment and there are no separate reportable segments as defined in
Accounting Standard, AS-17.
Note: "Previous Year's figure have been regrouped rearranged wherever considered necessary"
56
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
ATTENDENCE SLIP
PLEASE FILL THE ATTENDENCE SLIP AND HAND OVER AT THE ENTRANCE OF THE MEETING VENUE
I hereby record my presence at the 26th Annual General Meeting of Company held on Thursday, the 27th
September, 2018 at 10.00 a.m. at Amantran Hall, Near Vadodara Airport, Harani, Shyam Nagar, Karelibagh,
Vadodara - 390022, Gujarat.
Notes:
1. Members/Proxy holder are requested to bring their copies of the Annual Report with the Meeting.
2. Please carry with you this Attendance Slip and hand over the same duly signed at the space provided at
the entrance of the Meeting Hall.
57
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
PROXY FORM
CIN : L85100GJ1992PLC017397
Name of the Company : Tiaan Ayurvedic & Herbs Limited
Registered Office : 405, Patel Ashwamegh Complex, Sayajigunj, Vadodara – 390 005, Gujarat.
Registered Address
Email ID
Folio No. / Client ID
DP ID / L.F.No.
I/We being a member / members of _________ shares of the above named company, hereby appoint
as my/our proxy to attend and vote (on a poll) for me/us and on my/our behalf at the 26th Annual General
Meeting of Company held on Thursday, the September 27, 2018 at 10.00 a.m. at Amantran Hall, Near Vadodara
Airport, Harani, Shyam Nagar, Karelibagh, Vadodara - 390022, Gujarat and at any adjournment thereof in respect
of such resolutions as are indicated below:
58
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Note:
1. The proxy form in order to be effective should be duly completed and deposited at the Registered Office of
the Company, not less than 48 hours before the commencement of the Meeting.
2. It is optional to indicate your preference. If you leave the “For” or “Against” column blank against any or all
resolutions, you proxy will be entitled to vote in the manner as he/she may deem appropriate.
3. Your proxy will be entitled to vote in the manner as he/she may deem appropriate at 26th Annual General
Meeting of Members of the Company, to be held on Thursday, the 27th September, 2018 at 10:00 a.m. at
Amantran Hall, Near Vadodara Airport, Harani, Shyam Nagar, Karelibagh, Vadodara - 390022, Gujarat or at
any adjournment thereof.
59
26TH ANNUAL REPORT OF TIAAN AYURVEDIC & HERBS LIMITED
Amantran Hall, Near Vadodara Airport, Harani, Shyam Nagar, Karelibagh, Vadodara - 390022, Gujarat
60